Global phylogenomics of multidrug-resistant salmonella enterica serotype kentucky ST198
MetadataShow full item record
AbstractSalmonella enterica serotype Kentucky can be a common causative agent of salmonellosis, usually associated with consumption of contaminated poultry. Antimicrobial resistance (AMR) to multiple drugs, including ciprofloxacin, is an emerging problem within this serotype. We used whole-genome sequencing (WGS) to investigate the phylogenetic structure and AMR content of 121 S. enterica serotype Kentucky sequence type 198 isolates from five continents. Population structure was inferred using phylogenomic analysis and whole genomes were compared to investigate changes in gene content, with a focus on acquired AMR genes. Our analysis showed that multidrug-resistant (MDR) S. enterica serotype Kentucky isolates belonged to a single lineage, which we estimate emerged circa 1989 following the acquisition of the AMR-associated Salmonella genomic island (SGI) 1 (variant SGI1-K) conferring resistance to ampicillin, streptomycin, gentamicin, sulfamethoxazole and tetracycline. Phylo-geographical analysis indicates this clone emerged in Egypt before disseminating into Northern, Southern and Western Africa, then to the Middle East, Asia and the European Union. The MDR clone has since accumulated various substitution mutations in the quinolone-resistance-determining regions (QRDRs) of DNA gyrase (gyrA) and DNA topoisomerase IV (parC), such that most strains carry three QRDR mutations which together confer resistance to ciprofloxacin. The majority of AMR genes in the S. enterica serotype Kentucky genomes were carried either on plasmids or SGI structures. Remarkably, each genome of the MDR clone carried a different SGI1-K derivative structure; this variation could be attributed to IS26-mediated insertions and deletions, which appear to have hampered previous attempts to trace the clone’s evolution using sub-WGS resolution approaches. Several different AMR plasmids were also identified, encoding resistance to chloramphenicol, third-generation cephalosporins, carbapenems and/or azithromycin. These results indicate that most MDR S. enterica serotype Kentucky circulating globally result from the clonal expansion of a single lineage that acquired chromosomal AMR genes 30 years ago, and has continued to diversify and accumulate additional resistances to last-line oral antimicrobials. This article contains data hosted by Microreact. Copyright 2019 The Authors.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070787779&doi=10.1099%2fmgen.0.000269&partnerID=40&md5=b6508766eecb9d100b664f330a71d02e; http://hdl.handle.net/10713/10412
- Draft genome sequences of two ciprofloxacin-resistant Salmonella enterica subsp. enterica serotype Kentucky ST198 isolated from retail chicken carcasses in Egypt.
- Authors: Ramadan H, Gupta SK, Sharma P, Sallam KI, Hiott LM, Elsayed H, Barrett JB, Frye JG, Jackson CR
- Issue date: 2018 Sep
- Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland, USA (2011-2015).
- Authors: Haley BJ, Kim SW, Haendiges J, Keller E, Torpey D, Kim A, Crocker K, Myers RA, Van Kessel JAS
- Issue date: 2019 Jun
- National Prevalence of Salmonella enterica Serotype Kentucky ST198 with High-Level Resistance to Ciprofloxacin and Extended-Spectrum Cephalosporins in China, 2013 to 2017.
- Authors: Chen H, Song J, Zeng X, Chen D, Chen R, Qiu C, Zhou K
- Issue date: 2021 Jan 12
- Early strains of multidrug-resistant Salmonella enterica serovar Kentucky sequence type 198 from Southeast Asia harbor Salmonella genomic island 1-J variants with a novel insertion sequence.
- Authors: Le Hello S, Weill FX, Guibert V, Praud K, Cloeckaert A, Doublet B
- Issue date: 2012 Oct
- Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study.
- Authors: Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, Zerouali K, Weill FX
- Issue date: 2013 Aug